Coronary Calcification in Iraqi Middle-Aged Women With Previous Preeclampsia: A Cohort Study

Document Type : Original Article


1 Department of Medicine, College of Medicine, al-Mustansiriyah University, Baghdad, Iraq.

2 Department of Obstetrics and Gynecology, College of Medicine, al-Nahrain University, Baghdad, Iraq.


Background: Both preeclampsia and coronary artery calcification (CAC) are associated with an increased cardiovascular risk. As CAC is race and ethnicity-dependent, we test it in a sample of Iraqi population. We compared the presence of CAC in a cohort of middle-aged women with and without previous preeclampsia.
Methods: This retrospective cohort study on middle-aged Iraqi women used logistic regression models to compare 100 women with and 100 women without a history of preeclampsia. Other cardiovascular risk factors were assessed as potential covariates. Between September 2020 and January 2022, the women underwent a multidetector computed tomography for the assessment of the presence of CAC.
Results: CAC was found in 22% of patients with previous preeclampsia compared with 11% in those without previous preeclampsia. Body mass index, systolic and diastolic blood pressures, lipid indices, glucose levels, and hypertension were significantly related to previous preeclampsia. Age, waist circumference, diastolic blood pressure, glucose levels, hypertension, and diabetes were significantly associated with the presence of CAC. Women with previous preeclampsia had a 128% greater risk of CAC than women without this condition (OR, 2.28; 95% CI, 1.04 to 5). Age adjustments had no discernible effect on the relationship (OR, 2.39; 95% CI, 1.07 to 5.31).
Conclusions: Women with previous preeclampsia were more likely to have CAC than women with normotensive pregnancies in their middle age even after adjustments for age. Cardiovascular screening may be beneficial for women with a history of preeclampsia. (Iranian Heart Journal 2022; 23(4): 88-96)


  1. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ 2013; 347:f6564.
  2. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol 2020; 135:e237-e260.
  3. Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, Groot CJM de, Hofmeyr GJ. Pre-eclampsia. The Lancet 2016; 387:999–1011.
  4. Garrido-Gomez T, Dominguez F, Quiñonero A, Diaz-Gimeno P, Kapidzic M, Gormley M, et al. Defective decidualization during and after severe preeclampsia reveals a possible maternal contribution to the etiology. Proc Natl Acad Sci U S A 2017; 114:E8468-E8477.
  5. Burke SD, Zsengellér ZK, Khankin EV, Lo AS, Rajakumar A, DuPont JJ, et al. Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia. J Clin Invest 2016; 126:2561–74.
  6. Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002; 20:4368–80.
  7. Cirillo PM, Cohn BA. Pregnancy complications and cardiovascular disease death: 50-year follow-up of the Child Health and Development Studies pregnancy cohort. Circulation 2015; 132:1234–42.
  8. Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol 2013; 28:1–19.
  9. Theilen LH, Fraser A, Hollingshaus MS, Schliep KC, Varner MW, Smith KR, et al. All-Cause and Cause-Specific Mortality After Hypertensive Disease of Pregnancy. Obstet Gynecol 2016; 128:238–44.
  10. Bushnell C, McCullough L. Stroke prevention in women: synopsis of the 2014 American Heart Association/American Stroke Association guideline. Annals of Internal Medicine 2014; 160:853–7.
  11. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 139:e1082-e1143.
  12. Behrens I, Basit S, Melbye M, Lykke JA, Wohlfahrt J, Bundgaard H, et al. Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study. BMJ 2017; 358:j3078.
  13. Budoff MJ, Young R, Burke G, Jeffrey Carr J, Detrano RC, Folsom AR, et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). European Heart Journal 2018; 39:2401–8.
  14. Erbel R, Möhlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. Journal of the American College of Cardiology 2010; 56:1397–406.
  15. Cassidy-Bushrow AE, Bielak LF, Rule AD, Sheedy PF, Turner ST, Garovic VD, et al. Hypertension during pregnancy is associated with coronary artery calcium independent of renal function. J Womens Health (Larchmt) 2009; 18:1709–16.
  16. Beckman JP, Camp JJ, Lahr BD, Bailey KR, Kearns AE, Garovic VD, et al. Pregnancy history, coronary artery calcification and bone mineral density in menopausal women. Climacteric 2018; 21:53–9.
  17. Sabour S, Franx A, Rutten A, Grobbee DE, Prokop M, Bartelink M-L, et al. High blood pressure in pregnancy and coronary calcification. Hypertension 2007; 49:813–7.
  18. White WM, Mielke MM, Araoz PA, Lahr BD, Bailey KR, Jayachandran M, et al. A history of preeclampsia is associated with a risk for coronary artery calcification 3 decades later. Am J Obstet Gynecol 2016; 214:519.e1-519.e8.
  19. Zoet GA, Benschop L, Boersma E, Budde RPJ, Fauser, Bart C J M, van der Graaf Y, et al. Prevalence of Subclinical Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography in 45- to 55-Year-Old Women With a History of Preeclampsia. Circulation 2018; 137:877–9.
  20. Benschop L, Brouwers L, Zoet GA, Meun C, Boersma E, Budde RPJ, et al. Early Onset of Coronary Artery Calcification in Women With Previous Preeclampsia. Circ Cardiovasc Imaging 2020; 13:e010340.
  21. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2006; 113:30–7.
  22. Diehl CL, Brost BC, Hogan MC, Elesber AA, Offord KP, Turner ST, et al. Preeclampsia as a risk factor for cardiovascular disease later in life: validation of a preeclampsia questionnaire. Am J Obstet Gynecol 2008; 198:e11-3.
  23. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71:e13-e115.
  24. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. Journal of the American College of Cardiology 1990; 15:827–32.
  25. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002; 325:157–60.
  26. Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 2010; 56:166–71.
  27. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet 2004; 364:937–52.
  28. Engeland A, Bjørge T, Klungsøyr K, Skjærven R, Skurtveit S, Furu K. Preeclampsia in pregnancy and later use of antihypertensive drugs. Eur J Epidemiol 2015; 30:501–8.
  29. Stuart JJ, Tanz LJ, Missmer SA, Rimm EB, Spiegelman D, James-Todd TM, et al. Hypertensive Disorders of Pregnancy and Maternal Cardiovascular Disease Risk Factor Development: An Observational Cohort Study. Annals of Internal Medicine 2018; 169:224–32.
  30. Heida KY, Bots ML, Groot CJ de, van Dunné FM, Hammoud NM, Hoek A, et al. Cardiovascular risk management after reproductive and pregnancy-related disorders: A Dutch multidisciplinary evidence-based guideline. European Journal of Preventive Cardiology 2016; 23:1863–79.
  31. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European Heart Journal 2016; 37:2315–81.
  32. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal 2021; 42:3227–337.
  33. World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia, 2011.
  34. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. New England Journal of Medicine 2008;358:1336–45.
  35. Genders TSS, Pugliese F, Mollet NR, Meijboom WB, Weustink AC, van Mieghem CAG, et al. Incremental value of the CT coronary calcium score for the prediction of coronary artery disease. European Radiology 2010; 20:2331–40.